Disease Watch

References

• Schenck BR. Refractory subcutaneous abscesses caused by a fungus possibly related to the sporoctrichia. Bull. Johns Hopkins Hosp. 9, 286–290 (1898).
   Google Scholar
• Bustamante B, Campos PE. Endemic sporotrichosis. Carr. Opin. Infect. Dis. 14(2), 145–149 (2001).
   PubMed Web of Science ®Google Scholar
• ••Comprehensive review of cutaneoussporotrichosis.
   Google Scholar
• Nusbaun BP, Gulbas N, Horwitz SN. Sporotrichosis acquired from a cat. J. Am. Acad. Derrnatol. 8, 386–391 (1983).
   PubMed Web of Science ®Google Scholar
• Read SI, Sperling LC. Feline sporotrichosis: transmission to man. Arch. DerrnatoL 118, 429–431 (1982).
   PubMedGoogle Scholar
• Schwarz J, Kauffman CA. Occupational hazards from deep mycoses. Arch. Derrnatol. 113, 1270–1275 (1977).
   Google Scholar
• Cooper CR, Dixon DM, Salkin IF. Laboratory-acquired sporotrichosis. J. Med. Vet. Mycol. 30, 169–171 (1992).
   PubMedGoogle Scholar
• Rippon JVV. Sporotrichosis. In: Medical Mycology The Pathogenic Fungi and the Pathogenic Actinonycetes (2nd Edition). WB Saunders Co., PA, USA 277–302 (1982).
   Google Scholar
• Kwon-Chung KJ. Comparison of isolates of Sporothrix schenckii obtained from fixed cutaneous lesions with isolates from other types of lesions. J. Infect. Dis. 139, 424–431 (1979).
   PubMed Web of Science ®Google Scholar
• Sampaio SAP, Lacaz CS. Klinische und statistische untersuchungen ither sporotrichose in Sao Paulo. Hautarzt 10, 490–493 (1959).
   Google Scholar
• Pappas PG, Tellez I, Deep AE, Nolazco D, Holgado W, Bustamante B. Sporotrichosis in Peru: description of a Hyperendemic area. Clin. Infect. Dis. 30, 65–70 (2000).
   PubMed Web of Science ®Google Scholar
• ••Good description of epidemiological and clinical data from a hyperendemic area of sporotrichosis in Peru.
   Google Scholar
• Conti-Diaz IA. Sporotrichosis in Uruguay: Epidemiologic and Clinical Aspects. Proceedings of the Fifth International Conference on the Mycoses: superficial, cutaneous and subcutaneous infections. Caracas, Venezuela 27–30 April 1980. PAHO Scientific Publication No 396 312–321 (1980).
   Google Scholar
• Mayorga R, Caceres A, Toriello C, et al. Investigación de una zona endémica de esporotricosis en la regi6n de la Laguna de Ayarza, Guatemala. Bo]. of Sanit. Panarm 87(1), 20–34 (1978).
   Google Scholar
• Dismukes WE. Introduction to antifungal drugs. Clin. Infect. Dis. 30, 653–657 (2000).
   PubMed Web of Science ®Google Scholar
• Espinel-Ingroff A. In vitro activities of the new triazole Voriconazole (UK-109,496) against opportunistic filamentous and dimorphic fungi and common and emerging yeast pathogens. J. Clin. Microbic)]. 36, 198–202 (1998).
   PubMed Web of Science ®Google Scholar
• Van Custem J, Van Gerven F, Janssen AJ. Activity of orally, topically and parenterally administered itraconazole in the treatment of superficial and deep mycoses: animal models. Rev Infect. Dis. 9 (Suppl. 1), S15—S32 (1987).
   Google Scholar
• Restrepo A, Robledo J, Gomez I, et al. Itraconazole therapy in lymphangitis and cutaneous sporotrichosis. Arch. DerrnatoL122, 413–417 (1986).
   Google Scholar
• •Detailed description of cutaneous sporotrichosis treatment with itraconazole.
   Google Scholar
• Meneses G, Bustamante B, Holgado W De la Puente J. Itraconazol en el tratamiento de la esporotricosis subcutanea. Boleti'', de la Sociedad Peruana de Medicina Interna, 5(1), 2–3 (1992).
   Google Scholar
• Conti-Diaz I, Civita E, Gezuele E, et al. Treatment of human cutaneous sporotrichosis with itraconazole. Mycoses 35, 153–156 (1992).
   PubMed Web of Science ®Google Scholar
• Sharkey-Mathis PK, Kauffman CA, Graybill JR, et al. Treatment of Sporotrichosis with Itraconazole. Am. J. Med. 95, 279–285 (1993).
   PubMed Web of Science ®Google Scholar
• •Detailed description of itraconazole use in cutaneous and extracutaneous sporotrichosis.
   Google Scholar
• Noguchi H, Hiruma M, Kawada A. Case Report. Sporotrichosis successfully treated with itraconazole in Japan. Mycoses 42, 571–576 (1999).
   PubMed Web of Science ®Google Scholar
• Hull PR, Vismer HE Treatment of cutaneous sporotrichosis with terbinafine. BE J. Derrnatol 126 (Suppl. 39), 51–55 (1992).
   Google Scholar
• Chapman SW, Pappas P, Kauffmann C, et al. Comparative evaluation of the efficacy and safety of two doses of terbinafine (500 and 1000 mg/day) in the treatment of cutaneous or lymphocutaneous sporotrichosis. Mycoses 47, (2004) (In Press).
   PubMed Web of Science ®Google Scholar
• ••The only randomized, double-blind clinical trial enrolling a large number of patients with cutaneous sporotrichosis.
   Google Scholar
• Hall M, Monka C, Krupp P, O'Sullivan D. Safety of oral terbinafine: results of a post marketing surveillance study in 25,884 patients. Arch. Berm. 133, 1213–1219 (1997).
   Google Scholar
• Diaz M, Negroni R, Montero-Gei F, et al. A Pan-American 5-year study of fluconazole therapy for deep mycoses in the immunocompetent host. Clin. Infect. Dis. 14\(Suppl. 1), 568—S76 (1992).
   PubMed Web of Science ®Google Scholar
• Castro LGM, Belda W Cucé LC, Sampaio SAE Stevens DA. Successful treatment of sporotrichosis with oral fluconazole: a report of three cases. Br. Derrnatoi 128, 352–356 (1993).
   PubMed Web of Science ®Google Scholar
• Kauffman CA, Pappas PG, McKinsey DS, et al. Treatment of lymphocutaneous and visceral sporotrichosis with fluconazole. Clin. Infect. Dis. 22(1), 46–50 (1996).
   PubMed Web of Science ®Google Scholar
• Cullen SI, Mauceri AA, Warner N. Successful treatment of disseminated cutaneous sporotrichosis with ketoconazole. I Arn. Acad. DerrnatoL 27, 463–464 (1992).
   PubMed Web of Science ®Google Scholar
• Dismukes WE, Stamm AM, Graybill JR, et al. Treatment of systemic mycoses with Ketoconazole: Emphasis on toxicity and clinical response in 52 patients. Ann. Intern. Med. 98, 13–20 (1983).
   PubMed Web of Science ®Google Scholar
• Urabe H, Nagashima T. Mechanism of antifungal action of potassium iodide on sporotrichosis. Derrnatologia Internationalis8, 36–39 (1969).
   Google Scholar
• hoh M, Okamoto S, Kariya H. Survey of 200 cases of sporotrichosis. Derrnatologica 172, 209–213 (1986).
   PubMedGoogle Scholar
• Meneses G, Cabezas C, Bustamante B, et al. Reporte de 261 casos de esporotricosis entre 1987 y 1989. Centro Medico Santa Teresa, Abancay, Peru. Presented at the V Congreso Panarnericano de Inibctologia, Lima, Peru, April 7–10 (1991) (Abstract VI–9).
   Google Scholar
• Cabezas C, Bustamante B, Holgado W Begue R. Treatment of cutaneous sporotrichosis with one daily dose of potassium iodide. Pediatr. Infect. Dis.j 15, 352–354 (1996).
   PubMed Web of Science ®Google Scholar
• •The only evaluation of a single daily dose of potassium iodide in comparison to the traditional three doses per day.
   Google Scholar
• Hiruma M, Kawada A, Noguchi H, Ishibashi A, Conti Diaz IA. Hyperthermic treatment of sporotrichosis: experimental use of infrared and far infrared rays. Mycoses 35 (11–12), 293–299 (1992).
   Google Scholar
• Sterling JB, Haymann WR. Potassium iodide in dermatology. A 19th century drug for the 21th century uses, pharmacology, adverse effects and contraindications. jAm. Acad. DerrnatoL 43, 691–697 (2000).
   PubMed Web of Science ®Google Scholar
• Pluss JL, Opal SM. Pulmonary sporotrichosis: review of treatment an outcome. Medicine 65(3), 143–153 (1986).
   PubMed Web of Science ®Google Scholar
• •This classical paper describes in detail the clinical features of pulmonary sporotrichosis and its response to available treatments at that date.
   Google Scholar
• Ramirez J, Byrd RP Roy TM. Chronic cavitary pulmonary sporotrichosis: efficacy of oral Itraconazole. j Ky Med. Assoc. 96, 103–105 (1998).
   PubMedGoogle Scholar
• Ridgeway NA, Whitcomb FC, Erickson EE, Law SW Primary pulmonary sporotrichosis. Report of two cases. Am. J Med. 32, 153–160 (1962).
   PubMed Web of Science ®Google Scholar
• Lynch, PJ, Voorhes JJ, Harrell RE. Systemic sporotrichosis. Ann. Intern. Med. 73,23–30 (1970).
   PubMed Web of Science ®Google Scholar
• Breeling JL, Weinstein L. Pulmonary sporotrichosis treated with itraconazole. Chest 103(1), 313–314 (1993).
   PubMed Web of Science ®Google Scholar
• Dall L, Salzman G. Treatment of pulmonary sporotrichosis with ketoconazole. Rev. Infect. Dis. 9,795–798 (1987).
   PubMedGoogle Scholar
• Carrada-Bravo T Update on sporotrichosis. Aust. Fain. Physician 24(6), 1070–1071 (1996).
   Google Scholar
• Bayer AS, Scott VJ, Guze LB. Fungal arthritis: sporotrichal arthritis. Sernin. Arthritis Rheum. 9,66–74 (1979).
   PubMed Web of Science ®Google Scholar
• Howell SJ, Toohey JST. Sporotrichal arthritis in South Central Kansas. Cilia. Orthop. 346, 207–214 (1998).
   Google Scholar
• Winn RE. A contemporary view of sporotrichosis. Curr. Top. Med. Mycol. 6, 73–94 (1995).
   PubMedGoogle Scholar
• Downs NH, Hinthorn DR, Mhatre VR, Liu C. Intra-articular Amphotericin B treatment of Sporothrix schenckii arthritis. Arch. Intern. Med. 149,954–955 (1989).
   PubMedGoogle Scholar
• Badley AD, van Scoy RE. Long-term follow-up of multifocal osteoarticular sporotrichosis treated with itraconazole. Clin. Infect. Dis 23(2), 394–395 (1996).
   PubMed Web of Science ®Google Scholar
• DeHart DJ. Use of itraconazole for treatment of sporotrichosis involving a knee prosthesis. Clin. Infect. Dis. 21(2), 450 (1995).
   PubMed Web of Science ®Google Scholar
• Horsburgh CR, Cannady PB, Kirkpatrick CH. Treatment of fungal infection in the bones and joints with Ketoconazole. J Infect. Dis 147 (6), 1064–1069 (1983).
   PubMed Web of Science ®Google Scholar
• Calhoun DL, Waskin H, White MP, et al. Treatment of systemic sporotrichosis with ketoconazole. Rev Infect. Dis 13(1), 47–51 (1991).
   PubMedGoogle Scholar
• Graybill JR, Craven PC, DonoVan W Matthew EB. Ketoconazole therapy of systemic fungal infections. Inadequacy of standard dosage regimens. Ann. Rev Repir. Dis. 126,171–174 (1982).
   PubMed Web of Science ®Google Scholar
• Lipstein-Kresch E, Isemberg HD, Singer Co, Greenwald RA, Cooke. Disseminated Sporothrix schenckii infection with arthritis in a patient with acquired immunodeficiency syndrome. j Rheurnatol. 12,805–808 (1985).
   PubMed Web of Science ®Google Scholar
• Bihler MR, Luber HJ, Glueck HI, Estes SA. Disseminated sporotrichosis in a patient with HIV infection after treatment for acquired Factor VIII inhibitor. JAMA 256, 3125–3126 (1986).
   PubMed Web of Science ®Google Scholar
• Fitzpatrick JE, Eubanks S. Acquired immunodeficiency syndrome presenting as disseminated cutaneous sporotrichosis. Int. J Dermatol. 27,406–407 (1988).
   PubMed Web of Science ®Google Scholar
• Kurosawa A, Pollock SC, Collins MP, Kraff CR, Tso MO. Sporothrix schenckii endophthalmitis in a patient with human immunodeficiency virus infection. Arch. Ophtalma 106,376–380 (1988).
   PubMedGoogle Scholar
• Shaw JC, Levinson W, Montanaro A. Sporotrichosis in the acquired immunodeficiency syndrome. J Am. Acad. Dermatol. 21,1145–1147 (1989).
   PubMedGoogle Scholar
• Heller HM, Fuhrer J. Disseminated sporotrichosis in patients with AIDS: case report and review of the literature. AIDS5, 1243–1246 (1991).
   Google Scholar
• Keiser P, Whittle D. Sporotrichosis in human immunodeficiency virus-infected patients: report of a case. Rev Infect. Dis 13, 1027–1028 (1991).
   PubMedGoogle Scholar
• Oscherwitz SL, Rinaldi MG. Disseminated sporotrichosis in a patient infected with human immunodeficiency virus. Clin. Infect. Dis. 15,568–569 (1992).
   PubMed Web of Science ®Google Scholar
• Penn CC, Goldstein E, Bartholomew WR. Sporothrix schenckii in a patient with AIDS. Clin. Infect. Dis. 15,741–743 (1992).
   PubMed Web of Science ®Google Scholar
• Bolao F, Podzamczer D, Ventin M, Gudiol F. Efficacy of acute phase and maintenance therapy with itraconazole in an AIDS patient with sporotrichosis. Eur. j Clin. Microbia Infect. Dis. 13,609–612 (1994).
   PubMed Web of Science ®Google Scholar
• Donabedian H, O'Donnell E, Olszewski C, Mac Arthur R, Budd N. Disseminated cutaneous and meningeal sporotrichosis in an AIDS patient. Diagn. Microbia Infect. Dis. 18,111–115 (1994).
   PubMed Web of Science ®Google Scholar
• Dong JA, Chren MM, Elewski BE. Bonsai tree: risk factor for disseminated sporotrichosis. J Am. Acad. Dermatol. 33(5 Pt.1), 839–840 (1995).
   PubMed Web of Science ®Google Scholar
• Rotz LD, Slater LN, Wack MF, Boyd AL, Scott EN, Greenfield RA. Disseminated sporotrichosis with meningitis in a patient with AIDS. Infect. Dis. Clin. Practice 5, 566–568 (1996).
   Web of Science ®Google Scholar
• Morgan M. Reyes R. Invasive sinusitis due to Sporothrix schenckii, in a patient with AIDS. Cilia. Infect. Dis. 23,1319–1320 (1996).
   PubMed Web of Science ®Google Scholar
• Ticoras CJ, Schroeter AL, Hornbeck KL. Disseminated ulcerated papules and nodules. Cutaneous disseminated sporotrichosis. Arch. Dermatol. 132(8), 963–964 (1996).
   PubMedGoogle Scholar
• Gori S, Lupetti A, Moscato G, Parenti M, Lofaro A. Pulmonary sporotrichosis with hyphae in a human immunodeficiency virus-infected patient. A case report. Acta Cyta 41,519–521 (1997).
   PubMed Web of Science ®Google Scholar
• Al-Tawfiq JA, Kara K. Wools. Disseminated sporotrichosis and Sporothrix schenckiifungemia as the initial presentation of human immunodeficiency virus infection. Clin. Infect. Dis. 26, 1403–1406 (1998).
   PubMed Web of Science ®Google Scholar
• Goldani LZ, Aquino VR, Dargel AA. Disseminated cutaneous sporotrichosis in an AIDS patient receiving maintenance therapy with fluconazole for previous cryptococcal meningitis. Clin. Infect. Dis. 28,1337–1338 (1999).
   PubMed Web of Science ®Google Scholar
• Neto RJP, Machado AA, Castro G, Quaglio ASS, Martinez R. Esporotricose cutánea diseminada como manifestacao inicial da sindrome da imunodeficiencia adquirida: relato de caso. Rev. Soc. Bras. Med. Trop. 32,57–61 (1999).
   PubMedGoogle Scholar
• Ware AJ. Cockerell CJ, Skiest DJ, Kussman HM. Disseminated sporotrichosis with extensive cutaneous involvement in a patient with AIDS. J Am. Acad. Dermatol. 40,350–351 (1999).
   PubMed Web of Science ®Google Scholar
• Edwards CWL 3rd, Greer DL, Reuther. Disseminated osteoarticular sporotrichosis treatment in a patient with acquired immunodeficiency syndrome. South. Med. 93,803–806 (2000).
   Google Scholar
• Bonifaz A, Peniche A, Mercadillo P, Saul A. Successful treatment of AIDS-related disseminated cutaneous sporotrichosis with itraconazole. AIDS Patient Care STDs 15,603–606 (2001).
   PubMed Web of Science ®Google Scholar
• Aarestrup FM, Guerra RO, Vieira BJ, Cunha RM. Oral manifestation of sporotrichosis in AIDS patients: case report. Oral Dis. 7,134–136 (2001).
   PubMed Web of Science ®Google Scholar
• Rocha MM, Dassin T, Lira R, Lima EL, Severo LC, Londero AT. Sporotrichosis in patient with AIDS: report of a case and review. Rev. Iberoarn. Mica 18,133–136 (2001).
   PubMedGoogle Scholar
• Carvalho MT, de Castro AP, Baby C, Werner B, Filus Neto J, Queiroz-Telles F. Disseminated cutaneous sporotrichosis in a patient with AIDS: report of a case. Rev. Soc. Bras. Med. Trop. 35,655–659 (2002).
   PubMedGoogle Scholar
• Kauffman CA. Sporotrichosis. Clin. Infect. Dis. 29,231–237 (1999).
   PubMedGoogle Scholar
• Hampton DE, Adesina A, Chodosh J. Conjunctival sporotrichosis in the absence of antecedent trauma. Cornea 21(8), 831–833 (2002).
   PubMed Web of Science ®Google Scholar
• Vieira-Dias D, Sena CM, Oréfice F, Tanure MAG, Hamdan JS. Ocular and concomitant cutaneous sporotrichosis. Mycoses 40, 197–201 (1997).
   Google Scholar
• Gottlieb GS, Lesser CF, Holmes KK, Wald A. Disseminated sporotrichosis associated with treatment with immunosuppressants and tumor necrosis factor-a antogonists. CID37, 838–840 (2003).
   Google Scholar
• Espinel-Ingroff A. Comparison of in vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY-303366 against opportunistic filamentous and dimorphic fungi and yeasts. Clin. Microbiol 36, 2950–2956 (1998).
   Web of Science ®Google Scholar
• Ghannoum MA, Kuhn DM. Voriconazole — better chances for patients with invasive mycoses. Eur. J. Med. Res. 7, 242–256 (2002).
   PubMed Web of Science ®Google Scholar
• Mc Ginnis MR, Nordoff N, Li RK, Pasarell L, Warnock DVV. Sporothrix schenckii sensitivity to voriconazole, itraconazole and amphotericin B. Med. Mycol, 39, 369–371 (2001).
   PubMed Web of Science ®Google Scholar
• Fung-Tomc JC, Huczko E, Minassian B, Bonner DE In vitro activity of a new oral triazole, BMS-207147 (ER-30346). Antimicrob. Agents Chemother. 42, 313–318 (1998).
   PubMed Web of Science ®Google Scholar
• Morris Jones R, Youngchin S, Gomez BL, et al. Synthesis of melanin-like pigments by Sporothrix schenckii in vitro and during mammalian infection. Infect. Immun. 71(7), 4026–4033 (2003).
   Google Scholar
• Romero-Martinez R, Wheeler M, Guerrero-Plata A, et al. Biosynthesis and functions of melanin in Sporothrix schenckil Infect. II771771117. 68, 3696–3703 (2000).
   Google Scholar